<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/695227</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T20:35:54.000Z</news:publication_date>
      <news:title>FDA flags VEGF safety concern in Summit Therapeutics&apos; rejected bispecific cancer drug ivonescimab</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695310</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T20:32:16.000Z</news:publication_date>
      <news:title>FDA unveils Global Reliance Disclosure Program to speed international drug approvals</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695228</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T20:25:23.000Z</news:publication_date>
      <news:title>Beren Therapeutics secures FDA approval for Lembaz to treat infantile-onset Niemann-Pick disease type C</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695059</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T19:50:35.000Z</news:publication_date>
      <news:title>GSK receives accelerated FDA approval for oral lung cancer drug neladalkib</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695060</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T19:49:31.000Z</news:publication_date>
      <news:title>Heidi Overton faces Senate committee vote on FDA commissioner nomination amid uncertainty</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695103</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T19:44:14.000Z</news:publication_date>
      <news:title>HHS finalizes HIPAA privacy rule update to boost patient access to medical records</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695142</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T19:15:22.000Z</news:publication_date>
      <news:title>FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694555</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T18:32:28.000Z</news:publication_date>
      <news:title>Sellas Life Sciences reports Phase 3 success for AML vaccine galinpepimut-S</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694935</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T18:14:50.000Z</news:publication_date>
      <news:title>GOP and MAHA leaders dispute FDA nominee Heidi Overton&apos;s vaping policy record</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694767</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T17:49:24.000Z</news:publication_date>
      <news:title>CMS releases new AI roadmap; highlights from HLTH conference</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694787</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T17:18:00.000Z</news:publication_date>
      <news:title>FDA clears Roche&apos;s Wilserdly pill for certain ER-positive, HER2-negative breast cancers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694768</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T17:05:10.000Z</news:publication_date>
      <news:title>Flagship invests £100 million to launch AI-native biotech platform hub in the United Kingdom</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694556</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T16:34:45.000Z</news:publication_date>
      <news:title>Isomorphic Labs lands record $5 billion Series C, marking biggest private biotech raise ever</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695478</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T16:29:00.000Z</news:publication_date>
      <news:title>FDA rejects Summit’s ivonescimab, citing China‑centric data and missed survival benefit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694557</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T16:16:08.000Z</news:publication_date>
      <news:title>Health tech firms eye consumer-driven future at HLTH conference in Las Vegas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694599</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T16:07:21.000Z</news:publication_date>
      <news:title>U.S. loses measles elimination status, sparking political criticism of vaccination response</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694558</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T16:01:42.000Z</news:publication_date>
      <news:title>Cognito Therapeutics readies FDA submission for Alzheimer&apos;s light-and-sound headset after trial miss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694411</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:52:03.000Z</news:publication_date>
      <news:title>Isomorphic Labs raises record $5 billion in Series C, doubling its May funding</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694619</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:51:00.000Z</news:publication_date>
      <news:title>AI drugmaker Isomorphic Labs raises $5 billion in Series C round</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:44:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694413</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:40:44.000Z</news:publication_date>
      <news:title>Vertex awaits FDA decision on povetacicept for IgA nephropathy, analysts expect approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694431</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:27:50.000Z</news:publication_date>
      <news:title>Democrats rally behind Medicare for More as Trump&apos;s chief of staff backs the plan</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694387</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:13:36.000Z</news:publication_date>
      <news:title>Novo revamps NovoCare DTC platform as Roche’s Gazyva receives renewed approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694388</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T15:05:43.000Z</news:publication_date>
      <news:title>Priavoid&apos;s Alzheimer&apos;s pill PRI-002 fails Phase 2 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694244</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T14:36:45.000Z</news:publication_date>
      <news:title>AriBio&apos;s AR1001 shows 31% slower cognitive decline in monotherapy Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694263</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T14:25:41.000Z</news:publication_date>
      <news:title>FDA approves Roche&apos;s new breast cancer drug, poised to become its top-selling product</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694245</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T14:13:03.000Z</news:publication_date>
      <news:title>Sellas cancer vaccine cuts death risk by 41% in late-stage AML trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694051</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T14:00:01.000Z</news:publication_date>
      <news:title>b.well introduces safety tools for AI health chatbots</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/695202</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T13:33:00.000Z</news:publication_date>
      <news:title>Mount Sinai researchers map enzyme structure linked to rare metabolic disorder GA1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694095</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T13:27:01.000Z</news:publication_date>
      <news:title>John Powers III named permanent director of NIH&apos;s National Institute of Allergy and Infectious Diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693799</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:12:27.000Z</news:publication_date>
      <news:title>Genetix Biotherapeutics reports $327M YTD sales and projects $500M full-year revenue, marking profitability</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693800</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:01:00.000Z</news:publication_date>
      <news:title>Marrow Therapeutics raises $173M to develop bone-marrow-targeted gene therapies for blood disorders</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693775</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:00:50.000Z</news:publication_date>
      <news:title>Marrow Therapeutics secures $173 million to advance siRNA therapy for sickle cell, targeting CRISPR competition</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693776</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:00:39.000Z</news:publication_date>
      <news:title>Roche secures FDA approval for giredestrant, its first SERD for advanced breast cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693819</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:00:00.000Z</news:publication_date>
      <news:title>Marrow Therapeutics raises $173 million to develop infusion therapy for sickle cell disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693820</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:00:00.000Z</news:publication_date>
      <news:title>Sellas&apos; galinpepimut-S cuts death risk by 41% in Phase 3 AML trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693839</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T12:00:00.000Z</news:publication_date>
      <news:title>Marrow Therapeutics raises $173M to develop simpler alternative to gene therapies for sickle cell and beta thalassemia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694530</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T11:21:00.000Z</news:publication_date>
      <news:title>Medtronic to acquire Contego Medical for over $380 million to expand carotid and peripheral vascular portfolio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694362</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T09:31:00.000Z</news:publication_date>
      <news:title>Kyntra Bio drops mid-stage prostate cancer ADC program after failing efficacy criteria</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693318</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T09:30:00.000Z</news:publication_date>
      <news:title>RFK Jr. urges federal funding for faith-based addiction recovery centers, sparking expert concerns over medication access</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693316</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T09:30:00.000Z</news:publication_date>
      <news:title>Flavored nicotine tablets launch, raising concerns over appeal to youth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693315</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T09:30:00.000Z</news:publication_date>
      <news:title>Capsida proposes new monkey testing framework after fatal gene therapy trial for brain disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693317</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T09:30:00.000Z</news:publication_date>
      <news:title>Zero-tolerance signs in hospitals may not curb staff violence, authors argue</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694195</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T08:37:00.000Z</news:publication_date>
      <news:title>Isomorphic Labs secures $5 billion Series C, doubling its recent $2.1 billion raise</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694194</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T06:21:00.000Z</news:publication_date>
      <news:title>Panelists say 2027 could be Europe’s breakout year for biotech investment</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/692623</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T05:01:00.000Z</news:publication_date>
      <news:title>Biotech boards see more women, but CEO roles remain largely male-dominated</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693710</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T05:00:00.000Z</news:publication_date>
      <news:title>Cardinal Health advises correction of Presource kits containing recalled BD Alaris infusion sets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693414</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-17T03:04:00.000Z</news:publication_date>
      <news:title>Eli Lilly inks $5.9 billion partnership with Stipple Bio to develop precision oncology drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T23:45:36.000Z</news:publication_date>
      <news:title>Trump administration proposes new Medicare Advantage audit rule aiming to curb fraud and save $90 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691315</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T22:22:47.000Z</news:publication_date>
      <news:title>AriBio’s Alzheimer’s trial of repurposed erectile-dysfunction drug shows modest, inconclusive results</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694026</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T22:07:00.000Z</news:publication_date>
      <news:title>AriBio’s oral Alzheimer’s candidate shows significant benefit in monotherapy subgroup in phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691039</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T21:01:05.000Z</news:publication_date>
      <news:title>Eli Lilly inks up to $5.9 billion partnership with Stipple Bio to develop cancer therapies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690915</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T20:56:47.000Z</news:publication_date>
      <news:title>FDA approves Roche&apos;s Wilserdly for advanced HR-positive, HER2-negative breast cancer with ESR1 mutation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690747</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T19:59:14.000Z</news:publication_date>
      <news:title>Federal judge blocks Trump administration&apos;s visa length limits for foreign graduate students and postdocs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690703</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T19:17:34.000Z</news:publication_date>
      <news:title>AstraZeneca and Alexion receive FDA nod for Klygefa, a weekly self-administered myasthenia gravis therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690579</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:54:06.000Z</news:publication_date>
      <news:title>FDA proposes new classification that formally recognizes NAC as a dietary ingredient, ending its legal gray area</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690535</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:30:34.000Z</news:publication_date>
      <news:title>Helus Pharma reports Phase 3 depression trial shows symptom improvement but safety concerns linger</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690580</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:18:25.000Z</news:publication_date>
      <news:title>Expert warns that newer obesity GLP-1 drugs could spark access battles in low-income nations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/693750</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T18:12:00.000Z</news:publication_date>
      <news:title>Sellas vaccine shows 9-month overall survival gain in phase 3 AML trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690411</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:47:11.000Z</news:publication_date>
      <news:title>John Powers III named permanent director of NIAID after year-long vacancy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690431</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:14:00.000Z</news:publication_date>
      <news:title>FDA rejects Summit Therapeutics&apos; ivonescimab combo, citing lack of survival benefit in lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690432</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T17:00:00.000Z</news:publication_date>
      <news:title>CG Oncology’s cretostimogene cuts bladder cancer recurrence risk by 68% in Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690433</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:57:00.000Z</news:publication_date>
      <news:title>J&amp;J to acquire Ollin Biosciences for up to $3.3 billion, adding eye disease drug to its portfolio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690243</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:56:33.000Z</news:publication_date>
      <news:title>Biotech sector rebounds but gains are uneven, with Chinese firms and a large Sofinnova fund leading the surge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690244</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:52:09.000Z</news:publication_date>
      <news:title>Health-care providers turn to lawsuits over unpaid services as insurance costs squeeze paychecks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694846</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:20:00.000Z</news:publication_date>
      <news:title>ALDI recalls Priano protein tortelloni over possible Clostridium botulinum contamination</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690199</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T16:19:12.000Z</news:publication_date>
      <news:title>China adds CAR-T therapy to national insurance list, slashing price to $40,000</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690031</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:57:41.000Z</news:publication_date>
      <news:title>Parker Institute CEO Karen Knudsen says cancer research faces translation challenges</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690055</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:50:46.000Z</news:publication_date>
      <news:title>Helus Pharma’s Phase 3 trial shows strong depression benefit but safety concerns emerge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690056</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:21:03.000Z</news:publication_date>
      <news:title>J&amp;J buys Ollin Biosciences for $2.2 billion, taps Blackstone for $750 million Phase 3 eye drug funding</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690057</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T15:13:51.000Z</news:publication_date>
      <news:title>Eli Lilly to acquire Calytrix Bio for up to $1.5 billion to add blood-cancer assets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690058</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:58:12.000Z</news:publication_date>
      <news:title>FDA issues CRL for Summit Therapeutics&apos; ivonescimab, underscoring need for overall survival data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689887</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:53:32.000Z</news:publication_date>
      <news:title>Novo’s CagriSema shows over 20% weight loss at low doses in Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689888</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:39:13.000Z</news:publication_date>
      <news:title>Canadian biotech firms turn to Europe as US political uncertainty creates new market opportunities</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689863</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:37:18.000Z</news:publication_date>
      <news:title>Eli Lilly makes 14th acquisition of 2026, buying a blood-cancer biotech</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689889</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:35:21.000Z</news:publication_date>
      <news:title>Wave Life Sciences reports stronger weight-loss effect of WVE-007 in patients with higher BMI and excess body fat</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/694342</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:18:00.000Z</news:publication_date>
      <news:title>Naia Inc. recalls Chocolate Banana Bar Sorbetto over undeclared milk, egg and pistachio allergens</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689907</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T14:17:01.000Z</news:publication_date>
      <news:title>CDC finds 10% of U.S. adults used GLP-1 drugs in 2025, 20% of them took compounded versions; Russia may seize foreign drug IP</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689739</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:37:10.000Z</news:publication_date>
      <news:title>Democrats adopt &quot;Medicare for More&quot; as new health-care expansion message</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689740</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:07:47.000Z</news:publication_date>
      <news:title>STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:00:01.000Z</news:publication_date>
      <news:title>CG Oncology&apos;s oncolytic therapy shows positive Phase 3 results in non-muscle invasive bladder cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689741</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T13:00:00.000Z</news:publication_date>
      <news:title>CG Oncology&apos;s bladder cancer immunotherapy cuts tumor recurrence risk by 68% in study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689719</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:55:35.000Z</news:publication_date>
      <news:title>IQVIA report finds 90% of drugs launched 2016-2020 unlikely to recoup costs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689759</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:44:00.000Z</news:publication_date>
      <news:title>Eli Lilly to acquire Calytrix Bio for up to $1.5B, targeting rare blood cancers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689528</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T12:04:27.000Z</news:publication_date>
      <news:title>Flagship Pioneering invests £100 million to launch AI-focused biotech lab in London</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689295</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T11:00:00.000Z</news:publication_date>
      <news:title>VC John Doerr praises Tom Health AI tool as promising solution for primary care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690678</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:40:00.000Z</news:publication_date>
      <news:title>CG Oncology reports 68% drop in bladder cancer recurrence in phase 3 trial of cretostimogene</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689083</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>San Diego’s Seawolf Therapeutics raises $100M to develop non-viral gene therapies for obesity, muscle loss and osteoporosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688981</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Clinical AI pilots stall due to organizational environment, not technology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689107</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi for redosable DNA medicines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688979</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689127</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Versant and Eli Lilly commit $100 million to launch Seawolf Therapeutics, a non-viral gene-therapy startup</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688982</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>Choosing the Right AI Infrastructure Is Key to Accelerating Future Drug Discoveries</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688980</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T10:00:00.000Z</news:publication_date>
      <news:title>New polymer lidding technologies aim to make pharmaceutical blister packs fully recyclable</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690007</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:41:00.000Z</news:publication_date>
      <news:title>Biogen signs $411 million deal with TrimTech to develop protein degraders for neurodegenerative diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690006</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:37:00.000Z</news:publication_date>
      <news:title>Helus Pharma&apos;s modified psilocybin meets primary and secondary goals in phase 3 depression trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688961</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>AAMC leadership stays vigilant after midterm shift, urges continued congressional support for research</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688959</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Kennedy&apos;s MAHA Initiative Gains Momentum with Stephen Miller as White House Chief of Staff</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688960</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Proposal to start medical school after Step 1 exam to cut debt and boost diversity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688963</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>Physician burnout persists as hospitals push self-care instead of systemic fixes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688962</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:30:00.000Z</news:publication_date>
      <news:title>BeOne Medicines and Hengrui Lead STAT-WireScreen’s China Biotech Powerhouse 25 Ranking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689839</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:23:00.000Z</news:publication_date>
      <news:title>J&amp;J to acquire Ollin Biosciences for $2.2 billion to advance bispecific eye drug OLN324 against Roche’s Vabysmo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689838</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T09:03:00.000Z</news:publication_date>
      <news:title>Eli Lilly acquires Calytrix Bio in $1.5 billion deal to add myelofibrosis antibody to its pipeline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689670</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:57:00.000Z</news:publication_date>
      <news:title>Aclaris Therapeutics’ bosakitug fails Phase 2 eczema trial, TSLP program dropped</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688579</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:00:17.000Z</news:publication_date>
      <news:title>Sofinnova Partners raises €725 million for second crossover fund targeting late-stage European biotech firms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688643</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:00:00.000Z</news:publication_date>
      <news:title>Sofinnova Partners raises €725M crossover fund to back later-stage European biotech firms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/689334</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T06:10:00.000Z</news:publication_date>
      <news:title>Flagship Pioneering invests £100 million to launch AI-focused biotech incubation lab in London</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688267</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:25:00.000Z</news:publication_date>
      <news:title>Emerging biotech hubs like India could help lower global drug costs by scaling development</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688268</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:24:00.000Z</news:publication_date>
      <news:title>BridgeBio&apos;s Morgan Paull and Christine Zhang Named BioSpace 40 Under 40, Emphasize Patient-Centric Model</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688269</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:02:00.000Z</news:publication_date>
      <news:title>Biopharma firms showcase non-amyloid Alzheimer’s strategies at CTAD 2026 conference</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688270</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T05:01:00.000Z</news:publication_date>
      <news:title>Novartis and BMS pause autoimmune CAR-T trials after patient deaths and safety concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688890</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T03:47:00.000Z</news:publication_date>
      <news:title>Chinese authorities dismiss two researchers after child dies in gene‑editing study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/688554</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T02:32:00.000Z</news:publication_date>
      <news:title>Tandem Diabetes Care gets FDA clearance for tubeless insulin delivery system with up to 7-day wear</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/687527</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T01:25:43.000Z</news:publication_date>
      <news:title>Apple and OpenEvidence Begin Study of Experimental AI Health Chat App</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691559</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T00:00:00.000Z</news:publication_date>
      <news:title>Australian regulator seeks feedback on adding unique device IDs to medical device free‑sale certificates</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/690945</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T00:00:00.000Z</news:publication_date>
      <news:title>FDA rejects ivonescimab for lung cancer; J&amp;J to acquire Ollin Biosciences for up to $3.3B, Senate votes on FDA commissioner</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691558</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T00:00:00.000Z</news:publication_date>
      <news:title>Industry groups push for clearer FDA guidance on ANDA and 505(b)(2) filings amid rising patent thickets</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/691557</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T00:00:00.000Z</news:publication_date>
      <news:title>Experts discuss AI applications and challenges in regulatory conformity assessments</news:title>
    </news:news>
  </url>
</urlset>
